Skip to main content

Amphetamine Use Disorders clinical trials at UCSF
1 in progress, 0 open to new patients

  • Oxytocin HIV Meth Study

    Sorry, not yet accepting patients

    The purpose of this pilot study is to determine the tolerability, feasibility, and preliminary effectiveness of intranasal oxytocin administration prior to motivational enhancement group therapy sessions on laboratory-based measures of addiction, social connectedness, and stress responsivity in methamphetamine(meth)-using men who have sex with men (MSM). The investigators propose a randomized, double-blind, study of intranasal oxytocin versus placebo 40 IU prior to each of three Motivational Enhancement Group Therapy (MEGT) sessions in 28 mixed HIV sero-status MSM initiating treatment for amphetamine use disorder.

    San Francisco, California